• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1995年至2015年间丹麦系统性硬化症的发病率、死亡率及死亡原因趋势:一项全国性队列研究。

Trends in incidence, mortality, and causes of death associated with systemic sclerosis in Denmark between 1995 and 2015: a nationwide cohort study.

作者信息

Butt Sheraz A, Jeppesen Jørgen L, Fuchs Christine, Mogensen Mette, Engelhart Merete, Torp-Pedersen Christian, Gislason Gunnar H, Jacobsen Søren, Andersson Charlotte

机构信息

1Department of Internal Medicine and Cardiology, Amager Hvidovre, Glostrup Hospital, Valdemar Hansensvej 1-23, 2600 Glostrup, Denmark.

2Department of Dermatology, Bispebjerg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark.

出版信息

BMC Rheumatol. 2018 Dec 7;2:36. doi: 10.1186/s41927-018-0043-6. eCollection 2018.

DOI:10.1186/s41927-018-0043-6
PMID:30886986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6390621/
Abstract

BACKGROUND

To investigate the incidence and the mortality-rates of systemic sclerosis (SSc), its primary causes of death, and the temporal trends in events in Denmark during the last decades.

METHODS

Using the Danish National Patient Registry, we identified all persons aged ≥18 years with a first-time diagnosis of SSc (ICD-10 code M34, excluding M34.2) between 1995 and 2015.

RESULTS

A total of 2778 incident SSc cases were identified. The mean age at time of SSc diagnosis was 56 (standard deviation 15) years and 76% were women. The overall incidence rate (per 1,000,000 person-years) of diagnosed SSc was 24.4 (95% confidence interval 23.6-25.4), with a slight increase over the study period, age- and sex-adjusted incidence rate ratio 1.02 (95% confidence interval 1.01-1.02) per 1-year increase. The 1-year all-cause mortality rate per 100 person-years decreased from 6.1 (3.1-12.2) in 1995 to 5.3 (2.5-11.1) in 2015, sex- and age-adjusted hazard ratio 0.96 (95% CI 0.94-0.98) per 1-year increase. Over the period, the average age at SSc diagnosis increased and the proportion of women decreased, whereas the burden of comorbidities increased. One fifth of all deaths were attributable to cardiovascular causes, a fourth to pulmonary diseases, and 15% were due to cancer.

CONCLUSIONS

Within the last few decades, the incidence of SSc has increased and the 1-year mortality rate has decreased slightly in Denmark. Almost half of all deaths were attributable to cardiopulmonary causes.

摘要

背景

调查过去几十年丹麦系统性硬化症(SSc)的发病率、死亡率、主要死因及事件的时间趋势。

方法

利用丹麦国家患者登记系统,我们确定了1995年至2015年间所有首次诊断为SSc(国际疾病分类第十版代码M34,不包括M34.2)且年龄≥18岁的患者。

结果

共确定了2778例SSc新发病例。SSc诊断时的平均年龄为56岁(标准差15),76%为女性。确诊SSc的总体发病率(每100万人年)为24.4(95%置信区间23.6 - 25.4),在研究期间略有上升,年龄和性别调整后的发病率比值比为每增加1年1.02(95%置信区间1.01 - 1.02)。每100人年的1年全因死亡率从1995年的6.1(3.1 - 12.2)降至2015年的5.3(2.5 - 11.1),性别和年龄调整后的风险比为每增加1年0.96(95%置信区间0.94 - 0.98)。在此期间,SSc诊断时的平均年龄增加,女性比例下降,而合并症负担增加。所有死亡中有五分之一归因于心血管原因,四分之一归因于肺部疾病,15%归因于癌症。

结论

在过去几十年中,丹麦SSc的发病率有所上升,1年死亡率略有下降。几乎一半的死亡归因于心肺原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b19/6390621/3fb5d64f3ce1/41927_2018_43_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b19/6390621/e173697c9d33/41927_2018_43_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b19/6390621/52db7255dc1a/41927_2018_43_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b19/6390621/cd80fa889f51/41927_2018_43_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b19/6390621/3fb5d64f3ce1/41927_2018_43_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b19/6390621/e173697c9d33/41927_2018_43_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b19/6390621/52db7255dc1a/41927_2018_43_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b19/6390621/cd80fa889f51/41927_2018_43_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b19/6390621/3fb5d64f3ce1/41927_2018_43_Fig4_HTML.jpg

相似文献

1
Trends in incidence, mortality, and causes of death associated with systemic sclerosis in Denmark between 1995 and 2015: a nationwide cohort study.1995年至2015年间丹麦系统性硬化症的发病率、死亡率及死亡原因趋势:一项全国性队列研究。
BMC Rheumatol. 2018 Dec 7;2:36. doi: 10.1186/s41927-018-0043-6. eCollection 2018.
2
Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma).344例丹麦系统性硬化症(硬皮病)患者的死亡率及死因
Br J Rheumatol. 1998 Jul;37(7):750-5. doi: 10.1093/rheumatology/37.7.750.
3
Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan.台湾系统性硬化症的流行病学和死亡率:一项全国性人群研究。
Scand J Rheumatol. 2011;40(5):373-8. doi: 10.3109/03009742.2011.553736. Epub 2011 Mar 9.
4
Temporal Trends in Mortality in Patients with Systemic Sclerosis in Public Hospitals Across Mexico from 1998-2017.1998-2017 年墨西哥公立医院系统性硬化症患者死亡率的时间趋势。
Arch Med Res. 2022 Sep;53(6):610-616. doi: 10.1016/j.arcmed.2022.07.005. Epub 2022 Aug 26.
5
Secular Trends in Systemic Sclerosis Mortality in the United States from 1981 to 2020.1981 年至 2020 年美国系统性硬化症死亡率的长期趋势。
Int J Environ Res Public Health. 2022 Nov 16;19(22):15088. doi: 10.3390/ijerph192215088.
6
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.丹麦成骨不全患者的死亡率和发病率。
Dan Med J. 2018 Apr;65(4).
7
Increased incidence of multiple sclerosis in systemic sclerosis: A nationwide cohort study.系统性硬化症中多发性硬化症发病率的增加:一项全国性队列研究。
Prev Med. 2016 Mar;84:6-11. doi: 10.1016/j.ypmed.2015.12.006. Epub 2015 Dec 24.
8
Incidence and prevalence of systemic sclerosis in Thailand in year 2017-2020: a database from the Ministry of Public Health.2017-2020 年泰国系统性硬化症的发病率和患病率:来自公共卫生部的数据库。
Clin Rheumatol. 2023 Jul;42(7):1767-1774. doi: 10.1007/s10067-023-06550-7. Epub 2023 Mar 10.
9
Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA.美国系统性硬化症及系统性硬化症相关肺动脉高压的死亡率趋势。
ERJ Open Res. 2020 Jun 15;6(2). doi: 10.1183/23120541.00309-2019. eCollection 2020 Apr.
10
Trends in Systemic Sclerosis Mortality Over Forty-Eight Years, 1968-2015: A US Population-Based Study.系统性硬化症死亡率趋势:48 年研究(1968-2015):一项基于美国人群的研究。
Arthritis Care Res (Hoboken). 2021 Oct;73(10):1502-1510. doi: 10.1002/acr.24411. Epub 2021 Aug 31.

引用本文的文献

1
EPIDEMIOLOGICAL PROFILE OF PATIENTS WITH SYSTEMIC SCLEROSIS TREATED AT A QUATERNARY HOSPITAL IN THE STATE OF SÃO PAULO.圣保罗州一家四级医院治疗的系统性硬化症患者的流行病学概况。
Acta Ortop Bras. 2025 Jun 2;33(2):e287081. doi: 10.1590/1413-785220253302e287081. eCollection 2025.
2
Occupational history of psychosocial work environment exposures and risk of autoimmune rheumatic diseases - a Danish register-based cohort study.心理社会工作环境暴露的职业史与自身免疫性风湿病风险——一项基于丹麦登记处的队列研究。
Scand J Work Environ Health. 2025 May;51(3):226-236. doi: 10.5271/sjweh.4220. Epub 2025 Mar 17.
3
A scoping review of the epidemiology of systemic sclerosis and its organ manifestations: 2018-2024.

本文引用的文献

1
Mapping and predicting mortality from systemic sclerosis.系统性硬化症患者死亡率的预测与评估。
Ann Rheum Dis. 2017 Nov;76(11):1897-1905. doi: 10.1136/annrheumdis-2017-211448. Epub 2017 Aug 23.
2
Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE).1990年至2009年期间,来自西班牙全国硬皮病登记处(RESCLE)的987例系统性硬化症患者的死亡模式变化。
Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):40-47. Epub 2017 Feb 6.
3
Early Mortality in a Multinational Systemic Sclerosis Inception Cohort.
系统性硬化症及其器官表现的流行病学范围综述:2018 - 2024年
Curr Opin Rheumatol. 2025 Mar 1;37(2):103-112. doi: 10.1097/BOR.0000000000001063. Epub 2024 Oct 23.
4
Epidemiology of systemic sclerosis in Quebec, Canada: a population-based study.加拿大魁北克省系统性硬化症的流行病学:一项基于人群的研究。
Lancet Reg Health Am. 2024 Jun 8;35:100790. doi: 10.1016/j.lana.2024.100790. eCollection 2024 Jul.
5
Comorbidity and mortality in systemic sclerosis and matched controls: Impact of interstitial lung disease. A population based cohort study based on health registry data.系统性硬皮病及匹配对照患者的合并症和死亡率:间质性肺病的影响。一项基于健康登记数据的基于人群队列研究。
Chron Respir Dis. 2023 Jan-Dec;20:14799731231195041. doi: 10.1177/14799731231195041.
6
Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades.过去五十年中,系统性硬化症的死亡率在年轻患者中呈稳步下降趋势。
Rheumatology (Oxford). 2024 Feb 1;63(2):466-471. doi: 10.1093/rheumatology/kead233.
7
Incidence, prevalence and regional distribution of systemic sclerosis and related interstitial lung Disease: A nationwide retrospective cohort study.系统性硬化症及相关间质性肺病的发病率、患病率和地域分布:一项全国性回顾性队列研究。
Chron Respir Dis. 2022 Jan-Dec;19:14799731221125559. doi: 10.1177/14799731221125559.
8
Overall mortality.总死亡率。
J Scleroderma Relat Disord. 2021 Feb;6(1):3-10. doi: 10.1177/2397198320924873. Epub 2020 Jun 8.
9
Direct and indirect costs of systemic sclerosis and associated interstitial lung disease: A nationwide population-based cohort study.系统性硬化症及其相关间质性肺病的直接和间接成本:一项全国范围内基于人群的队列研究。
Respirology. 2022 May;27(5):341-349. doi: 10.1111/resp.14234. Epub 2022 Feb 27.
10
Mortality in Inflammatory Rheumatic Diseases: Lithuanian National Registry Data and Systematic Review.炎症性风湿性疾病的死亡率:立陶宛国家注册数据和系统评价。
Int J Environ Res Public Health. 2021 Nov 24;18(23):12338. doi: 10.3390/ijerph182312338.
多发性硬化症发病队列的早期死亡率。
Arthritis Rheumatol. 2017 May;69(5):1067-1077. doi: 10.1002/art.40027. Epub 2017 Apr 6.
4
Update of EULAR recommendations for the treatment of systemic sclerosis.EULAR 系统性硬皮病治疗推荐更新。
Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9.
5
Systemic Sclerosis and Malignancy: A Review of Current Data.系统性硬化症与恶性肿瘤:当前数据综述
J Clin Med Res. 2016 Sep;8(9):625-32. doi: 10.14740/jocmr2606w. Epub 2016 Jul 30.
6
Incidence of Systemic Lupus Erythematosus and Lupus Nephritis in Denmark: A Nationwide Cohort Study.丹麦系统性红斑狼疮和狼疮性肾炎的发病率:一项全国性队列研究。
J Rheumatol. 2016 Jul;43(7):1335-9. doi: 10.3899/jrheum.151221. Epub 2016 May 1.
7
Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis.系统性硬化症相关间质性肺疾病的近期治疗方法
Clin Med Insights Circ Respir Pulm Med. 2016 Jan 19;9(Suppl 1):97-110. doi: 10.4137/CCRPM.S23315. eCollection 2015.
8
The Danish National Patient Registry: a review of content, data quality, and research potential.丹麦国家患者登记处:内容、数据质量及研究潜力综述
Clin Epidemiol. 2015 Nov 17;7:449-90. doi: 10.2147/CLEP.S91125. eCollection 2015.
9
Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening.癌症与硬皮病:一种具有恶性肿瘤筛查意义的副肿瘤性疾病。
Curr Opin Rheumatol. 2015 Nov;27(6):563-70. doi: 10.1097/BOR.0000000000000222.
10
Application of the 2013 ACR/EULAR classification criteria for systemic sclerosis to patients with Raynaud's phenomenon.2013年美国风湿病学会/欧洲抗风湿病联盟系统性硬化症分类标准在雷诺现象患者中的应用。
Arthritis Res Ther. 2015 Mar 22;17(1):77. doi: 10.1186/s13075-015-0594-5.